Application of Synthetic Biology in Promoting Preclinical and Clinical Advances of Bacterial Anti-Cancer Therapy
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

National Key R & D Program of China (2018YFA0902701), Strategic Priority Research Program of Chinese Academy of Sciences (XDB29050501, XDPB18), National Natural Science Foundation of China (32025022, 3201101136), Shenzhen Science Technology and Innovation Commission (KQTD2015033117210153, JCYJ20170818164139781)

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Bacteriotherapy is one of the important direction in the field of cancer therapy. The increasing development of synthetic biology provides more diversified, more effective and safer therapeutic strategies for bacterial anti-cancer therapy. In this review, the excellent clinical examples in the field of bacterial anti-cancer therapy are summarized, the current research progress and bottleneck problems are introduced in detail. The application of synthetic biology in promoting the clinical development of live bacterial therapeutics is also discussed. Moreover, the important role and the future development trend of synthetic biology are prospected in view of the effectiveness and biosafety of clinical live bacterial therapeutics.

    Reference
    Related
    Cited by
Get Citation

LIU Chenli, DONG Yuxuan, GUO Xuan. Application of Synthetic Biology in Promoting Preclinical and Clinical Advances of Bacterial Anti-Cancer Therapy[J]. Journal of Integration Technology,2021,10(4):78-92

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:
  • Revised:
  • Adopted:
  • Online: July 26,2021
  • Published:
Article QR Code